{ "description": "Définition des phases de l'essai utilisées dans la base de données ECLAIRE", "_filename": "CodeSystem-eclaire-study-phase-source-code-system.json", "package_name": "ans.fhir.fr.eclaire", "date": "2023-10-24T08:16:05+00:00", "publisher": "ANS", "jurisdiction": [ { "coding": [ { "code": "FR", "system": "urn:iso:std:iso:3166", "display": "FRANCE" } ] } ], "content": "complete", "name": "EclaireStudyPhaseSourceCS", "type": null, "experimental": null, "resourceType": "CodeSystem", "title": "Définition des phase de l'essai utilisés dans la base de données ECLAIRE", "package_version": "0.2.0", "status": "draft", "id": "1d3750ef-d2fc-460b-9ec8-6dad2c78aa8c", "kind": null, "count": 12, "url": "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system", "concept": [ { "code": "jarde-early", "display": "Jardé phase précoce" }, { "code": "phase-I-first-admin", "display": "Human Pharmacology (Phase I) - First administration to humans" }, { "code": "phase-I-bioequivalence", "display": "Human Pharmacology (Phase I) - Bioequivalence Study" }, { "code": "phase-I-other", "display": "Human Pharmacology (Phase I) - Other" }, { "code": "phase-I-II-first-admin", "display": "Phase I and Phase II (Integrated) - First administration to humans" }, { "code": "phase-I-II-first-bioequivalence", "display": "Phase I and Phase II (Integrated) - Bioequivalence Study" }, { "code": "phase-I-II-other", "display": "Phase I and Phase II (Integrated) - Other" }, { "code": "phase-II", "display": "Therapeutic exploratory (Phase II)" }, { "code": "phase-II-III", "display": "Phase II and Phase III (Integrated)" }, { "code": "phase-III", "display": "Therapeutic confirmatory (Phase III)" }, { "code": "phase-IV", "display": "Therapeutic use (Phase IV)" }, { "code": "phase-III-IV", "display": "Phase III and phase IV (Integrated)" } ], "caseSensitive": true, "version": "0.2.0", "contact": [ { "name": "ANS", "telecom": [ { "value": "https://esante.gouv.fr", "system": "url" } ] } ] }